Status:
COMPLETED
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain
Lead Sponsor:
Mahidol University
Conditions:
Peripheral Neuropathy
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study to evaluated Long term outcome after serial Lidocaine infusion when compared with placebo in peripheral neuropathic pain patients in acute stage (less than 6 months) at 3 mon...
Detailed Description
Peripheral nerve injury may give rise to severe and long-lasting types of pains which are often resistant to treatment such as opioid, tricyclic antidepressant or anticonvulsant. Lidocaine infusion ha...
Eligibility Criteria
Inclusion
- Peripheral neuropathic pain from peripheral nerve injury within 6 months after injury
- Well understand to Thai language in writing or listening
Exclusion
- Underlying Heart disease or Arrhythmia
- Allergy to lidocaine, Gabapentin, Carbamazepine, tramadol
- History of epilepsy
- History of lidocaine used
- Underlying Psychiatric disease
- History of drug abuse
- Pregnancy and nursing
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT02217267
Start Date
August 1 2014
End Date
February 1 2018
Last Update
November 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine Siriraj Hospital Mahidol University
Bangkoknoi, Bangkok, Thailand, 10700